Antios Therapeutics

Clinical-stage biopharmaceutical company focused on developing innovative therapies for viral diseases. Antios Therapeutics aims to address unmet medical needs by creating novel treatments that target viral infections, differentiating itself through its advanced research and development capabilities. The company's primary target demographic includes patients suffering from viral diseases and healthcare providers seeking new therapeutic options.